Brain Tumors, Primary: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for cancers of the brain and spinal cord. Trials are listed according to the type of tumor. To learn more about a study, choose from the list below.


Showing 14 trials
Titlesort icon Investigator
A Phase I Study of Hypofractionated Stereotactic Radiosurgery with Bevacizumab to Treat Recurrent Malignant Glioma
[Protocol 11-057]
Omuro, Antonio, MD
A Phase I Study of LEQ506, an Oral Smoothened Inhibitor, in Patients with Advanced Solid Tumors
[Protocol 10-182]
Ho, Alan, MD, PhD
A Phase I Study of RO4929097 in Combination with Standard Radiotherapy and Temozolomide for Newly Diagnosed Malignant Glioma
[Protocol 09-177]
Omuro, Antonio, MD
A Phase I Study of XL765 in Combination with Temozolomide in Patients with Malignant Gliomas
[Protocol 08-057]
Omuro, Antonio, MD
A Phase Ib Study of Cediranib in Combination with Cilengitide in Patients with Recurrent Glioblastoma
[Protocol 10-157]
Kaley, Thomas, MD
A Phase II Study of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Ependymoma in Adults
[Protocol 11-146]
Omuro, Antonio, MD
A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low- Grade and Anaplastic Ependymoma
[Protocol 09-031]
Omuro, Antonio, MD
A Phase II Trial of Intensive Chemotherapy & Autotransplantation in Patients with Newly Diagnosed Anaplastic Oligodendroglioma
[Protocol 02-089]
Omuro, Antonio, MD
A Phase III Study of Radiation Therapy with and without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
[Protocol 11-120]
Kaley, Thomas, MD
A Study of [18F]-ML-10 as a PET Imaging Radiotracer for the Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy
[Protocol 08-116]
Beal, Kathryn, MD
Glioma International Case-Control Study
[Protocol 10-073]
Olson, Sara, PhD
Image-Guided Stereotactic Biopsy of High Grade Gliomas
[Protocol 09-060]
Bradbury, Michelle, MD
Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
[Protocol 09-058]
Kaley, Thomas, MD
Pilot Study of Weekly High-Dose Erlotinib for Recurrent High-Grade Gliomas with the EGFR variant III Mutation
[Protocol 10-125]
Mellinghoff, Ingo, MD